Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Vogel, Lotte K ^a   Sæbø, Mona ^b   Høyer, Helle ^b,c   Kopp, Tine Iskov ^d   Vogel, Ulla ^e   Godiksen, Sine ^a   Frenzel, Franz B ^a   Hamfjord, Julian ^f   Bowitz Lothe, Inger Marie ^f   Johnson, Egil ^f,g   Kure, Elin H ^b,f   Andersen, Vibeke ^h,i,j  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^c TELEMARK HOSPITAL   (Norway)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h Hospital of Southern Jutland   (Denmark)

ⁱ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^j VIBORG HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CANCER TISSUE; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTESTINE; MAJOR CLINICAL STUDY; MALE; MUCOSA; NORWEGIAN (PEOPLE); PTGS2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; ADENOCARCINOMA; ADENOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADENOMA; AGED; ALLELES; CARCINOGENESIS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GENOTYPE; HUMANS; INTESTINES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RNA, MESSENGER;

EID: 84919888555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105254     Document Type: Article

References (38)

1. Karsa LV, Lignini TA, Patnick J, Lambert R, Sauvaget C (2010) The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol 24: 381-396.
2. Huxley RR, nsary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180.
3. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U (2010) Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 10: 484.
4. Andersen V, Holst R, Vogel U (2013) Systematic review: diet-gene interactions and the risk of colorectal cancer. Aliment Pharmacol Ther 37: 383-391.
5. Andersen V, Egeberg R, Tjonneland A, Vogel U (2012) Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study. BMC Cancer 12: 183. doi:10.1186/1471-2407-12-183: 183-12.
6. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U (2011) Heme oxygenase-1 polymorphism is not associated with risk of colorectal cancer: a Danish prospective study. Eur J Gastroenterol Hepatol 23: 282-285. 10.1097/MEG.0b013e3283417f76 [doi].
7. Zhang X, Miao X, Tan W, Ning B, Liu Z, et al. (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129: 565-576. (Pubitemid 41096644)
8. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, et al. (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22: 1631-1636.
9. Brosens LA, Iacobuzio-Donahue CA, Keller JJ, Hustinx SR, Carvalho R, et al. (2005) Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Clin Cancer Res 11: 4090-4096. 11/11/4090 [pii];10.1158/1078-0432. CCR-04-2379 [doi].
10. Moore AE, Young LE, Dixon DA (2012) A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation. Oncogene 31: 1592-1598. onc2011349 [pii];10.1038/onc.2011.349 [doi].
11. Benamouzig R, Uzzan B, Martin A, Deyra J, Little J, et al. (2010) Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. Gut 59: 622-629.
12. Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356: 2131-2142. (Pubitemid 47010839)
13. Saebo M, Skjelbred CF, Brekke LK, Bowitz Lothe IM, Hagen PC, et al. (2008) CYP1A2 164 A->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Res 28: 2289-2295.
14. Skjelbred CF, Saebo M, Nexo BA, Wallin H, Hansteen IL, et al. (2006) Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study. BMC Cancer 6: 175.: 175.
15. Skjelbred CF, Saebo M, Hjartaker A, Grotmol T, Hansteen IL, et al. (2007) Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer %19; 7: 228.: 228.
16. Skjelbred CF, Saebo M, Wallin H, Nexo BA, Hagen PC, et al. (2006) Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 6: 67.: 67.
17. Hansen R, Saebo M, Skjelbred CF, Nexo BA, Hagen PC, et al. (2005) GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 229: 85-91. (Pubitemid 41262543)
18. Lorentzen A, Vogel LK, Lewinsky RH, Saebo M, Skjelbred CF, et al. (2007) Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer 7: 192. 1471-2407-7-192 [pii];10.1186/1471-2407-7-192 [doi].
19. Vogel LK, Saebo M, Skjelbred CF, Abell K, Pedersen ED, et al. (2006) The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 6: 176. 1471-2407-6-176 [pii];10.1186/1471-2407-6-176 [doi].
20. Andersen V, Vogel U, Godiksen S, Frenzel FB, Saebo M, et al. (2013) Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis. PLoS One 8: e72119. 10.1371/journal.pone.0072119 [doi];PONE-D-13-10259 [pii].
21. Skovbjerg H, Anthonsen D, Lothe IM, Tveit KM, Kure EH, et al. (2009) Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer 9: 136. 1471-2407-9-136 [pii];10.1186/1471-2407-9-136 [doi].
22. Saebo M, Skjelbred CF, Nexo BA, Wallin H, Hansteen IL, et al. (2006) Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas. BMC Cancer 6: 208. 1471-2407-6-208 [pii];10.1186/1471-2407-6-208 [doi].
23. Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, et al. (2009) Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer 9: 201. 1471-2407-9-201 [pii];10.1186/1471-2407-9-201 [doi].
24. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, et al. (2011) The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 11: 65. 1471-2407-11-65 [pii];10.1186/1471-2407-11-65 [doi].
25. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, et al. (2005) Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: experience from the large-scale NORCCAP screening trial. Eur J Cancer Prev 14: 373-379. (Pubitemid 41104946)
26. Anonymous (2008) ClinicalTrials.gov (available; https://clinicaltrials. gov/. Accessed 2014 Aug 4.).
27. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
28. Ostergaard M, Ernst A, Labouriau R, Dagiliene E, Krarup HB, et al. (2009) Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population. Scand J Gastroenterol 44: 65-73.
29. Andersen V, Nimmo E, Krarup HB, Drummond H, Christensen J, et al. (2011) Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Inflamm Bowel Dis 17: 937-946.
30. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, et al. (2007) Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617: 138-146. (Pubitemid 46386090)
31. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, et al. (2008) Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639: 89-100.
32. Dong J, Dai J, Zhang M, Hu Z, Shen H (2010) Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis. J Gastroenterol Hepatol 25: 1042-1050.
33. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, et al. (2008) Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639: 89-100. S0027-5107(07)00398-3 [pii];10.1016/j.mrfmmm.2007. 11.004 [doi].
34. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, et al. (2007) Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617: 138-146. S0027-5107(07)00023-1 [pii];10.1016/j.mrfmmm.2007.01.005 [doi].
35. Cao H, Xu Z, Long H, Li XQ, Li SL (2010) The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis. Tohoku J Exp Med 222: 15-21.
36. Andersen V, Holst R, Kopp TI, Tjonneland A, Vogel U (2013) Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study. PLoS One 8: e78366.
37. Friis S, Poulsen AH, Sorensen HT, Tjonneland A, Overvad K, et al. (2009) Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control 20: 731-740.
38. Vinogradova Y, Coupland C, Hippisley-Cox J (2011) Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer 105: 452-459.